Advertisement

Pediatric Radiology

, Volume 46, Issue 3, pp 357–364 | Cite as

Antenatal and postnatal radiologic diagnosis of holocarboxylase synthetase deficiency: a systematic review

  • Sahan P. Semasinghe Bandaralage
  • Soheil Farnaghi
  • Joel M. Dulhunty
  • Alka KothariEmail author
Original Article

Abstract

Background

Holocarboxylase synthetase deficiency results in impaired activation of enzymes implicated in glucose, fatty acid and amino acid metabolism. Antenatal imaging and postnatal imaging are useful in making the diagnosis. Untreated holocarboxylase synthetase deficiency is fatal, while antenatal and postnatal biotin supplementation is associated with good clinical outcomes. Although biochemical assays are required for definitive diagnosis, certain radiologic features assist in the diagnosis of holocarboxylase synthetase deficiency.

Objective

To review evidence regarding radiologic diagnostic features of holocarboxylase synthetase deficiency in the antenatal and postnatal period.

Materials and methods

A systematic review of all published cases of holocarboxylase synthetase deficiency identified by a search of Pubmed, Scopus and Web of Science.

Results

A total of 75 patients with holocarboxylase synthetase deficiency were identified from the systematic review, which screened 687 manuscripts. Most patients with imaging (19/22, 86%) had abnormal findings, the most common being subependymal cysts, ventriculomegaly and intraventricular hemorrhage.

Conclusion

Although the radiologic features of subependymal cysts, ventriculomegaly, intraventricular hemorrhage and intrauterine growth restriction may be found in the setting of other pathologies, these findings should prompt consideration of holocarboxylase synthetase deficiency in at-risk children.

Keywords

Biotin Fetus Holocarboxylase synthetase deficiency Intraventricular hemorrhage Neonate Subependymal cysts Ventriculomegaly 

Notes

Acknowledgments

We thank Dr. Tanya Wood, radiologist, Redcliffe Hospital, for assistance with images and providing peer review of the manuscript. We also thank the parents of the child with holocarboxylase synthetase deficiency delivered at our institution for providing consent to include clinical information and relevant imaging pictures.

Compliance with ethical standards

Conflicts of interest

None

Supplementary material

247_2015_3492_MOESM1_ESM.doc (1.9 mb)
Supplement 1 (DOC 1973 kb)

References

  1. 1.
    Hou J-W (2004) Biotin responsive multiple carboxylase deficiency presenting as diabetic ketoacidosis. Chang Gung M J 27:129–133Google Scholar
  2. 2.
    Munnich A, Frĕzal J, Saudubray JM et al (1981) Biotin dependent multiple carboxylase deficiency presenting as a congenital lactic acidosis. Eur J Pediatr 137:203–206PubMedGoogle Scholar
  3. 3.
    Kliegman R, Nelson WE (eds) (2011) Nelson textbook of pediatrics, 19th edn. Saunders, PhiladelphiaGoogle Scholar
  4. 4.
    Orphanet (2011) Holocarboxylase synthetase deficiency. Orphanet http://www.orpha.net/consor/cgi-bin/OC_Exp.php?Expert=79242. Accessed 17 Nov 2014
  5. 5.
    Esparza EM, Golden AS, Hahn SH et al (2011) Infantile periorificial and intertriginous dermatitis preceding sepsis‐like respiratory failure. Pediatr Dermatol 28:333–334CrossRefPubMedGoogle Scholar
  6. 6.
    Thuy LP, Jurecki E, Nemzer L et al (1999) Prenatal diagnosis of holocarboxylase synthetase deficiency by assay of the enzyme in chorionic villus material followed by prenatal treatment. Clin Chim Acta 284:59–68CrossRefPubMedGoogle Scholar
  7. 7.
    Packman S, Cowan MJ, Golbus MS et al (1982) Prenatal treatment of biotin responsive multiple carboxylase deficiency. Lancet 1:1435–1438CrossRefPubMedGoogle Scholar
  8. 8.
    Thuy LP, Belmont J, Nyhan WL et al (1999) Prenatal diagnosis and treatment of holocarboxylase synthetase deficiency. Prenat Diagn 19:108–112CrossRefPubMedGoogle Scholar
  9. 9.
    Roth KS (1985) Prenatal treatment of multiple carboxylase deficiency. Ann N Y Acad Sci 447:263–271CrossRefPubMedGoogle Scholar
  10. 10.
    Liberati A, Altman DG, Tetzlaff J et al (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ 339:332–336CrossRefGoogle Scholar
  11. 11.
    Wilson CJ, Myer M, Darlow BA et al (2005) Severe holocarboxylase synthetase deficiency with incomplete biotin responsiveness resulting in antenatal insult in samoan neonates. J Pediatr 147:115–118CrossRefPubMedGoogle Scholar
  12. 12.
    Slavin TP, Zaidi SJ, Neal C et al (2014) Clinical presentation and positive outcome of two siblings with holocarboxylase synthetase deficiency caused by a homozygous L216R mutation. JIMD Rep 12:109–114PubMedCentralCrossRefPubMedGoogle Scholar
  13. 13.
    Hui J, Law E, Chung C et al (2012) The first reported HLCS gene mutation causing holocarboxylase synthetase deficiency in a Vietnamese patient. World J Pediatr 8:278–280CrossRefPubMedGoogle Scholar
  14. 14.
    Tammachote R, Janklat S, Tongkobpetch S et al (2010) Holocarboxylase synthetase deficiency: novel clinical and molecular findings. Clin Genet 78:88–93CrossRefPubMedGoogle Scholar
  15. 15.
    Yokoi K, Ito T, Maeda Y et al (2009) A case of holocarboxylase synthetase deficiency with insufficient response to prenatal biotin therapy. Brain Dev 31:775–778CrossRefPubMedGoogle Scholar
  16. 16.
    Van Hove JLK, Josefsberg S, Freehauf C et al (2008) Management of a patient with holocarboxylase synthetase deficiency. Mol Genet Metab 95:201–205PubMedCentralCrossRefPubMedGoogle Scholar
  17. 17.
    Rao AN, Iyer RB, Kavitha J et al (2008) Biotin metabolism defect - a case report. Indian J Clin Biochem 23:407–409PubMedCentralCrossRefPubMedGoogle Scholar
  18. 18.
    Bailey LM, Ivanov RA, Jitrapakdee S et al (2008) Reduced half‐life of holocarboxylase synthetase from patients with severe multiple carboxylase deficiency. Hum Mutat 29:E47–E57CrossRefPubMedGoogle Scholar
  19. 19.
    Lund AM, Joensen F, Hougaard DM et al (2007) Carnitine transporter and holocarboxylase synthetase deficiencies in the Faroe Islands. J Inherit Metab Dis 30:341–349CrossRefPubMedGoogle Scholar
  20. 20.
    Chou IC, Wang CS, Lin WD et al (2006) Holocarboylase synthetase deficiency: report of one case. Acta Paediatr Taiwan 47:309–311PubMedGoogle Scholar
  21. 21.
    Seymons K, De Moor A, De Raeve H et al (2004) Dermatologic signs of biotin deficiency leading to the diagnosis of multiple carboxylase deficiency. Pediatr Dermatol 21:231–235CrossRefPubMedGoogle Scholar
  22. 22.
    Santer R, Muhle H, Suormala T et al (2003) Partial response to biotin therapy in a patient with holocarboxylase synthetase deficiency: clinical, biochemical, and molecular genetic aspects. Mol Genet Metab 79:160–166CrossRefPubMedGoogle Scholar
  23. 23.
    Tang NLS, Hui J, Yong CKK et al (2003) A genomic approach to mutation analysis of holocarboxylase synthetase gene in three Chinese patients with late-onset holocarboxylase synthetase deficiency. Clin Biochem 36:145–149CrossRefPubMedGoogle Scholar
  24. 24.
    Morrone A, Malvagia S, Donati MA et al (2002) Clinical findings and biochemical and molecular analysis of four patients with holocarboxylase synthetase deficiency. Am J Med Genet 111:10–18CrossRefPubMedGoogle Scholar
  25. 25.
    Yang X, Aoki Y, Li X et al (2001) Structure of human holocarboxylase synthetase gene and mutation spectrum of holocarboxylase synthetase deficiency. Hum Genet 109:526–534CrossRefPubMedGoogle Scholar
  26. 26.
    Carpenter KH, Wilcken B, Christodoulou J et al (2000) Holocarboxylase synthetase deficiency: urinary metabolites masked by gross ketosis. J Inherit Metab Dis 23:845–846CrossRefGoogle Scholar
  27. 27.
    Touma E, Suormala T, Baumgartner ER et al (1999) Holocarboxylase synthetase deficiency: report of a case with onset in late infancy. J Inherit Metab Dis 22:115–122CrossRefPubMedGoogle Scholar
  28. 28.
    Sakamoto O, Suzuki Y, Aoki Y et al (1998) Molecular analysis of new Japanese patients with holocarboxylase synthetase deficiency. J Inherit Metab Dis 21:873–874CrossRefPubMedGoogle Scholar
  29. 29.
    Suormala T, Fowler B, Jakobs C et al (1998) Late-onset holocarboxylase synthetase-deficiency: pre- and post-natal diagnosis and evaluation of effectiveness of antenatal biotin therapy. Eur J Pediatr 157:570–575CrossRefPubMedGoogle Scholar
  30. 30.
    Suormala T, Fowler B, Duran M et al (1997) Five patients with a biotin-responsive defect in holocarboxylase formation: evaluation of responsiveness to biotin therapy in vivo and comparative biochemical studies in vitro. Pediatr Res 41:666–673CrossRefPubMedGoogle Scholar
  31. 31.
    Squires L, Betz B, Umfleet J et al (1997) Resolution of subependymal cysts in neonatal holocarboxylase synthetase deficiency. Dev Med Child Neurol 39:267–269CrossRefPubMedGoogle Scholar
  32. 32.
    Law LK, Lau CY, Pang CP et al (1997) An unusual case of multiple carboxylase deficiency presenting as generalized pustular psoriasis in a Chinese boy. J Inherit Metab Dis 20:106–107CrossRefPubMedGoogle Scholar
  33. 33.
    Gibson KM, Bennett MJ, Nyhan WL et al (1996) Late-onset holocarboxylase synthetase deficiency. J Inherit Metab Dis 19:739–742CrossRefPubMedGoogle Scholar
  34. 34.
    Aoki Y, Suzuki Y, Sakamoto O et al (1995) Molecular analysis of holocarboxylase synthetase deficiency: a missense mutation and a single base deletion are predominant in Japanese patients. Biochim Biophys Acta 1272:168–174CrossRefPubMedGoogle Scholar
  35. 35.
    Dabbagh O, Brismar J, Gascon GG et al (1994) The clinical spectrum of biotin-treatable encephalopathies in Saudi Arabia. Brain Dev 16 Suppl:72–80CrossRefPubMedGoogle Scholar
  36. 36.
    Livne M, Gibson KM, Amir N et al (1994) Holocarboxylase synthetase deficiency: a treatable metabolic disorder masquerading as cerebral palsy. J Child Neurol 9:170–172CrossRefPubMedGoogle Scholar
  37. 37.
    Fuchshuber A, Suormala T, Roth B et al (1993) Holocarboxylase synthetase deficiency: early diagnosis and management of a new case. Eur J Pediatr 152:446–449CrossRefPubMedGoogle Scholar
  38. 38.
    Briones P, Ribes A, Vilaseca MA et al (1989) A new case of holocarboxylase synthetase deficiency. J Inherit Metab Dis 12:329–330CrossRefPubMedGoogle Scholar
  39. 39.
    Michalski AJ, Berry GT, Segal S (1989) Holocarboxylase synthetase deficiency: 9-year follow-up of a patient on chronic biotin therapy and a review of the literature. J Inherit Metab Dis 12:312–316CrossRefPubMedGoogle Scholar
  40. 40.
    Holme E, Jacobson CE, Kristiansson B (1988) Biotin-responsive multiple carboxylase deficiency in an 8-year-old boy with normal serum biotinidase and fibroblast holocarboxylase-synthetase activities. J Inherit Metab Dis 11:270–276CrossRefPubMedGoogle Scholar
  41. 41.
    Williams ML, Packman S, Cowan MJ (1983) Alopecia and periorificial dermatitis in biotin-responsive multiple carboxylase deficiency. J Am Acad Dermatol 9:97–103CrossRefPubMedGoogle Scholar
  42. 42.
    Sherwood WG, Saunders M, Robinson BH et al (1982) Lactic acidosis in biotin-responsive multiple carboxylase deficiency caused by holocarboxylase synthetase deficiency of early and late onset. J Pediatr 101:546–550CrossRefPubMedGoogle Scholar
  43. 43.
    Narisawa K, Arai N, Igarashi Y et al (1982) Clinical and biochemical findings on a child with multiple biotin-responsive carboxylase deficiencies. J Inherit Metab Dis 5:67–68CrossRefPubMedGoogle Scholar
  44. 44.
    Wolf B, Hsia YE, Sweetman L et al (1981) Multiple carboxylase deficiency: clinical and biochemical improvement following neonatal biotin treatment. Pediatrics 68:113PubMedGoogle Scholar
  45. 45.
    Packman S, Sweetman L, Baker H et al (1981) The neonatal form of biotin-responsive multiple carboxylase deficiency. J Pediatr 99:418–420CrossRefPubMedGoogle Scholar
  46. 46.
    Roth KS, Allan L, Yang W et al (1981) Serum and urinary biotin levels during treatment of holocarboxylase synthetase deficiency. Clin Chim Acta 109:337–340CrossRefPubMedGoogle Scholar
  47. 47.
    De Castro M, Zand DJ, Lichter-Konecki U et al (2015) Severe neonatal holocarboxylase synthetase deficiency in West African siblings. JIMD Rep 20:1–4PubMedCentralCrossRefPubMedGoogle Scholar
  48. 48.
    Sakamoto O, Suzuki Y, Li X et al (2000) Diagnosis and molecular analysis of an atypical case of holocarboxylase synthetase deficiency. Eur J Pediatr 159:18–22CrossRefPubMedGoogle Scholar
  49. 49.
    Sakamoto O, Suzuki Y, Li X et al (1999) Relationship between kinetic properties of mutant enzyme and biochemical and clinical responsiveness to biotin in holocarboxylase synthetase deficiency. Pediatr Res 46:671–676CrossRefPubMedGoogle Scholar
  50. 50.
    Aoki Y, Li X, Sakamoto O et al (1999) Identification and characterization of mutations in patients with holocarboxylase synthetase deficiency. Hum Genet 104:143–148CrossRefPubMedGoogle Scholar
  51. 51.
    Suzuki Y, Aoki Y, Sakamoto O et al (1996) Enzymatic diagnosis of holocarboxylase synthetase deficiency using apo-carboxyl carrier protein as a substrate. Clin Chim Acta 251:41–52CrossRefPubMedGoogle Scholar
  52. 52.
    Roth KS, Yang W, Foremann JW et al (1980) Holocarboxylase synthetase deficiency: a biotin-responsive organic acidemia. J Pediatr 96:845–849CrossRefPubMedGoogle Scholar
  53. 53.
    Cowan MJ, Wara DW, Packman S et al (1979) Multiple biotin-dependent carboxylase deficiencies associated with defects in T-cell and B-cell immunity. Lancet 2:115–118CrossRefPubMedGoogle Scholar
  54. 54.
    Packman S, Sweetman L, Yoshino M et al (1981) Biotin-responsive multiple carboxylase deficiency of infantile onset. J Pediatr 99:421–423CrossRefPubMedGoogle Scholar
  55. 55.
    Burri BJ, Sweetman L, Nyhan WL (1985) Heterogeneity of holocarboxylase synthetase in patients with biotin-responsive multiple carboxylase deficiency. Am J Hum Genet 37:326–337PubMedCentralPubMedGoogle Scholar
  56. 56.
    Bassi A, Galeone M, Arunachalam M et al (2014) A 2-month-old boy with desquamative skin fold dermatitis. J Pediatr 164:211CrossRefPubMedGoogle Scholar
  57. 57.
    Arbuckle HA, Morelli J (2006) Holocarboxylase synthetase deficiency presenting as ichthyosis. Pediatr Dermatol 23:142–144CrossRefPubMedGoogle Scholar
  58. 58.
    van der Weiden S, Steggerda SJ, Te Pas AB et al (2010) Routine TORCH screening is not warranted in neonates with subependymal cysts. Early Hum Dev 86:203–207CrossRefPubMedGoogle Scholar
  59. 59.
    Shen EY, Huang FY (1985) Subependymal cysts in normal neonates. Arch Dis Child 60:1072–1074PubMedCentralCrossRefPubMedGoogle Scholar
  60. 60.
    Makhoul IR, Zmora O, Tamir A et al (2001) Congenital subependymal pseudocysts: own data and mata-analysis of the literature. Isr Med Assoc J 3:178–183PubMedGoogle Scholar
  61. 61.
    Bats AS, Molho M, Senat MV et al (2002) Subependymal pseudocysts in the fetal brain: prenatal diagnosis of two cases and review of the literature. Ultrasound Obstet Gynecol 20:502–505CrossRefPubMedGoogle Scholar
  62. 62.
    Fernandez Alvarez JR, Amess PN, Gandhi RS (2009) Diagnostic value of subependymal pseudocysts and choroid plexus cysts on neonatal cerebral ultrasound: a meta-analysis. Arch Dis Child Fetal Neonatal Ed 94:F443–F446CrossRefPubMedGoogle Scholar
  63. 63.
    Griffiths PD, Reeves MJ, Morris JE et al (2010) A prospective study of fetuses with isolated ventriculomegaly investigated by antenatal sonography and in utero MR imaging. AJNR Am J Neuroradiol 31:106–111CrossRefPubMedGoogle Scholar
  64. 64.
    Graham E, Duhl A, Ural S et al (2001) The degree of antenatal ventriculomegaly is related to pediatric neurological morbidity. J Matern Fetal Med 10:258–263CrossRefPubMedGoogle Scholar
  65. 65.
    McKechnie L, Vasudevan C, Levene M (2012) Neonatal outcome of congenital ventriculomegaly. Semin Fetal Neonatal Med 17:301–307CrossRefPubMedGoogle Scholar
  66. 66.
    Breeze AC, Alexander PM, Murdoch EM et al (2007) Obstetric and neonatal outcomes in severe fetal ventriculomegaly. Prenat Diagn 27:124–129CrossRefPubMedGoogle Scholar
  67. 67.
    Gardosi J (2012) Customised assessment of fetal growth potential: implications for perinatal care. Arch Dis Child Fetal Neonatal Ed 97:F314–F317CrossRefPubMedGoogle Scholar
  68. 68.
    Rossi AC, Prefumo F (2014) Additional value of fetal magnetic resonance imaging in the prenatal diagnosis of central nervous system anomalies: a systematic review of the literature. Ultrasound Obstet Gynecol 44:388–393CrossRefPubMedGoogle Scholar
  69. 69.
    Verburg B, Fink AM, Reidy K et al (2015) The contribution of MRI after fetal anomalies have been diagnosed by ultrasound: correlation with postnatal outcomes. Fetal Diagn Ther. doi: 10.1159/000380821 PubMedGoogle Scholar
  70. 70.
    Tabor A, Philip J, Madsen M et al (1986) Randomised controlled trial of genetic amniocentesis in 4606 low-risk women. Lancet 1:1287–1293CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2016

Authors and Affiliations

  • Sahan P. Semasinghe Bandaralage
    • 1
    • 2
  • Soheil Farnaghi
    • 3
  • Joel M. Dulhunty
    • 4
    • 5
  • Alka Kothari
    • 4
    • 5
    Email author
  1. 1.Gold Coast Hospital and Health ServiceSouthportAustralia
  2. 2.School of MedicineGriffith UniversitySouthportAustralia
  3. 3.Caboolture HospitalCabooltureAustralia
  4. 4.Redcliffe Hospital, RedcliffeQueenslandAustralia
  5. 5.School of MedicineThe University of QueenslandHerstonAustralia

Personalised recommendations